CO4790157A1 - Sales de calcio de antibioticos lipopetidicos y procedimiento para su preparacion - Google Patents

Sales de calcio de antibioticos lipopetidicos y procedimiento para su preparacion

Info

Publication number
CO4790157A1
CO4790157A1 CO99009231A CO99009231A CO4790157A1 CO 4790157 A1 CO4790157 A1 CO 4790157A1 CO 99009231 A CO99009231 A CO 99009231A CO 99009231 A CO99009231 A CO 99009231A CO 4790157 A1 CO4790157 A1 CO 4790157A1
Authority
CO
Colombia
Prior art keywords
calcium salt
interrupted
lipopetidic
antibiotics
procedure
Prior art date
Application number
CO99009231A
Other languages
English (en)
Spanish (es)
Inventor
Michael Kurz
Schmidt Frank Rainer
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of CO4790157A1 publication Critical patent/CO4790157A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045—Actinoplanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CO99009231A 1998-02-25 1999-02-16 Sales de calcio de antibioticos lipopetidicos y procedimiento para su preparacion CO4790157A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19807972A DE19807972A1 (de) 1998-02-25 1998-02-25 Lipopeptidantibiotika-Calciumsalze, Verfahren zu ihrer Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
CO4790157A1 true CO4790157A1 (es) 1999-05-31

Family

ID=7858906

Family Applications (1)

Application Number Title Priority Date Filing Date
CO99009231A CO4790157A1 (es) 1998-02-25 1999-02-16 Sales de calcio de antibioticos lipopetidicos y procedimiento para su preparacion

Country Status (15)

Country Link
US (1) US6624143B1 (https=)
EP (1) EP1068223B1 (https=)
JP (1) JP4402833B2 (https=)
AR (1) AR016713A1 (https=)
AT (1) ATE223433T1 (https=)
AU (1) AU2725299A (https=)
CA (1) CA2322052C (https=)
CO (1) CO4790157A1 (https=)
DE (2) DE19807972A1 (https=)
DK (1) DK1068223T3 (https=)
ES (1) ES2182489T3 (https=)
PT (1) PT1068223E (https=)
TW (1) TW559623B (https=)
WO (1) WO1999043700A1 (https=)
ZA (1) ZA991482B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2394313A1 (en) 1999-12-15 2001-06-21 Cubist Pharmaceuticals, Inc. Novel lipopeptides as antibacterial agents
MXPA02006029A (es) 1999-12-15 2004-08-23 Cubist Pharm Inc Lipopeptidos novedosos como agentes antibacterianos.
AU784812B2 (en) 1999-12-15 2006-06-29 Merck Sharp & Dohme Corp. Lipopeptides as antibacterial agents
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides
NZ554405A (en) † 2000-12-18 2009-04-30 Cubist Pharm Inc Method for preparing crystalline and crystal-like forms of purified lipopeptides
US7125844B2 (en) 2002-01-03 2006-10-24 Migenix Inc. Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same
AU2004252174A1 (en) 2003-06-26 2005-01-06 Migenix Inc. Compositions of lipopeptide antibiotic derivatives and methods of use thereof
US7795207B2 (en) 2005-11-21 2010-09-14 Harald Labischinski Lipopeptide compositions
DE102005056194A1 (de) * 2005-11-21 2007-07-12 Combinature Biopharm Ag Neue Lipopeptid Zusammensetzungen
GB0821540D0 (en) 2008-11-25 2008-12-31 Merlion Pharmaceuticals Pte Ltd Lipopeptide compounds and their use
PL2379580T3 (pl) * 2008-12-22 2014-05-30 Merck Sharp & Dohme Nowe środki przeciwbakteryjne do leczenia zakażeń wywołanych bakteriami Gram-dodatnimi
SG10201407724YA (en) 2009-11-23 2014-12-30 Cubist Pharm Inc Daptomycin compositions and related methods
US10647746B2 (en) 2016-04-08 2020-05-12 Versitech Limited Antibacterial cyclic lipopeptides
US11667674B2 (en) 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
CN109476704B (zh) * 2016-04-08 2022-08-16 港大科桥有限公司 抗菌环脂肽

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4800162A (en) * 1987-04-01 1989-01-24 Sepracor, Inc. Method for resolution of steroisomers in multiphase and extractive membrane reactors
GB8720980D0 (en) * 1987-09-07 1987-10-14 Lepetit Spa Derivatives
US5039789A (en) * 1988-04-11 1991-08-13 Eli Lilly And Company A54145 cyclic peptides
US6309440B1 (en) * 1998-08-25 2001-10-30 Thomas T. Yamashita Method and composition for promoting and controlling growth of plants
TW455591B (en) * 1993-06-08 2001-09-21 Hoechst Ag Lipopeptides from actinoplanes sp. with pharmacological action, process for their production and the use thereof
DE4411025A1 (de) * 1994-03-30 1995-10-05 Hoechst Ag Lipopeptid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US6291680B1 (en) * 1997-06-18 2001-09-18 Fujisawa Pharmaceutical Co., Ltd. Production process

Also Published As

Publication number Publication date
TW559623B (en) 2003-11-01
JP2002528382A (ja) 2002-09-03
US6624143B1 (en) 2003-09-23
AU2725299A (en) 1999-09-15
ATE223433T1 (de) 2002-09-15
DE59902568D1 (de) 2002-10-10
CA2322052C (en) 2009-09-29
EP1068223B1 (de) 2002-09-04
CA2322052A1 (en) 1999-09-02
AR016713A1 (es) 2001-07-25
WO1999043700A1 (de) 1999-09-02
DK1068223T3 (da) 2002-12-30
ZA991482B (en) 1999-08-25
EP1068223A1 (de) 2001-01-17
PT1068223E (pt) 2003-01-31
DE19807972A1 (de) 1999-08-26
JP4402833B2 (ja) 2010-01-20
ES2182489T3 (es) 2003-03-01

Similar Documents

Publication Publication Date Title
CO4790157A1 (es) Sales de calcio de antibioticos lipopetidicos y procedimiento para su preparacion
NO177428C (no) Anvendelse av salter av metaller med carboxylsyrer for stabilisering av organopolysiloxanmasser
MX9303124A (es) Compuestos organicos de benzodiazepina, procedimiento para su preparacion y formulaciones farmaceuticas que los contienen.
BR9306004A (pt) Lubrificantes para correias transportadoras de corrente e sua aplicação
BR9815464A (pt) Polìmero, processo de preparação de polìmeros, utilização de um polìmero, composição, associação de pelo menos um polìmero com pelo menos um composto e composição cosmética
ES2132676T3 (es) Composiciones de peroxigeno.
AR107694A1 (es) Heteroarilos inhibidores de pad4
ES2179850T3 (es) Sistema de liberacion de sustancia activa.
DK1273299T3 (da) Minoxidilinindeholdende praparater
MX173498B (es) Procedimiento para la preparacion de acidos 4£- oxo-4h (1)-benzopiran-8-il| alcanoicos y derivados.
ES2069244T3 (es) Composicion cosmetica, farmaceutica o alimentaria que comprende vesiculas lipidicas.
AR116694A1 (es) COMPUESTOS AGONISTAS b DEL RECEPTOR DE LA HORMONA TIROIDEA
ES2188011T3 (es) Agente de contraste para la reproduccion en imagenes de infartos y necrosis.
ES2141256T3 (es) Composiciones antimicrobianas sinergeticas que contienen 2-(tiocianometiltio)benzotiazol y un acido organico.
ES2108772T3 (es) Derivados de aminofosfonato substituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MX174635B (es) Composicion liquida suavizante
FI923680A0 (fi) Foerfarande foer framstaellning av (2r,3r) cis-b-fenylglysidinsyra.
AR004625A1 (es) Composicion de un oseo activo que comprende una sustancia de un oseo activo y un carrier bilogico de dicha sustancia,composicion farmaceutica que comprende dicha composicion de un oseo-activo,y uso de dicha composicion para la preparacion de un medicamento
ES2193779T3 (es) Derivados de cromano.
MX9303587A (es) Producto para el cuidado de lentes de contacto, para lentes de contacto duros o blandos.
CO4560461A1 (es) Procedimiento para la descomposicion del hidroperoxido de cicloalquilo
ES2084878T3 (es) Sal colina de diclofenac, un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen.
AR020587A1 (es) Metodo para la profilaxis o tratamiento de una infeccion bacteriana en mamiferos, uso de un inhibidor de oxido nitrico sintasa inducible para lafabricacion de medicamentos y formulacion farmaceutica
ES2146972T3 (es) Compuesto superfluidificante para composiciones de cemento.
ES2116554T3 (es) Derivados de la lisina con grupo n-epsilon-alcoxi o alcenoxicarbonilo, su preparacion y su utilizacion, en composiciones cosmeticas, farmaceuticas, higienicas o alimenticias.